|Daily Range||0.00 - 0.00|
|52-Week Range||0.00 - 0.00|
|Dividend (Yield)||0.00 (0.0%)|
|Average Daily Volume||0|
|Current FY EPS||4.05|
Teva's sales are hurt by generic competition and lost sales of its own generics.
Horizon Pharmaceuticals enjoys a short-lived bounce following Q3 results.
Horizon Pharma's big one-day drop could mean good news.